3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
However, such stocks exist. Here are three high-yield dividend stocks that could soar 22% to 49% over the next 12 months, according to Wall Street. 1. Pfizer Pfizer (NYSE: PFE) stock has been on a downward trajectory for nearly two and a half years. Blame it mainly on declining demand for the company's COVID-19 vaccine and oral antiviral drug Paxlovid. However, Pfizer also faces the looming loss of exclusivity for multiple products. Despite this bad news, analysts remain perhaps surprisingly bullish about Pfizer. The average analysts' 12-month price target reflects an upside potential of around 22%. Not everyone on Wall Street is enamored with Pfizer. One analyst surveyed by LSEG in April recommended selling the stock. But over half of the analysts polled rated Pfizer as a buy or a strong buy. I don't know if Pfizer will hit the 12-month price target. However, I agree with the overall optimism about the stock over the long run. The drugmaker's launches of new products should g
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- The New Menopause: Dr Mary Claire Haver On Shame And Stigma Free Aging [Forbes]Forbes
- Global Vertigo Treatment Market Forecast to Reach $1.6 Billion by 2030, Driven by the Rise in Benign Paroxysmal Positional Vertigo Prevalence [Yahoo! Finance]Yahoo! Finance
- FirstFT: Investors pull money from Starwood $10bn property fund [FT.com - Mergermarket]FT.com - Mergermarket
- FirstFT: Investors pull money from Starwood $10bn property fund [Financial Times (FT.com) (UK)]Financial Times
- Pfizer agrees to pay up to $250M to settle Zantac cancer lawsuits - report [Seeking Alpha]Seeking Alpha
PFE
Earnings
- 5/1/24 - Beat
PFE
Sec Filings
- 5/9/24 - Form S-8
- 5/8/24 - Form 10-Q
- 5/1/24 - Form 4
- PFE's page on the SEC website